$172.87
-5.33-2.99%
Last update: Nov 5, 9:40 AM
Repligen Corp (RGEN) Stock Price, Quote, News & History
RGENNASDAQ
Repligen to acquire BioLife Solutions for $1.5B to boost cell therapy bioprocessing capabilities and expand global reach.
You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.
Other companies in Repligen’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Repligen has a consensus price target of $180.61.
The stock price for Repligen (NASDAQ: RGEN) is $172.87 last updated November 5, 2026 at 9:40 AM EST.
There are no upcoming dividends for Repligen.
Repligen does not have any upcoming earnings scheduled.
There is no upcoming split for Repligen.
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins,...
